By Dr. Brian Rudman, Co-Founder and Chief Medical Officer, Formula Wellness
Picture it. You're out on a Saturday night. Someone you've never met walks up, holds out a pill and says, "Take this. It'll make you skinnier. Bonus: no hangover tomorrow."
Would you actually take it? Of course not. Nobody reading this would. You don't know who this person is, where the pill came from, or what's actually in it. And if something goes wrong, there's no one to call.
So why on earth would you inject something into your body under exactly the same conditions?
That's the gray-market peptide trade in one sentence. Every week I talk to smart, successful, health-conscious people doing exactly this, usually to save $50 or $100. I want to be as clear as I can as I shake my head: it isn't worth it.
My Inbox Is the Problem
I get one to two emails a day from peptide "pharmacies," overseas labs and research-chemical sellers who want Formula to carry their products. Glossy PDFs. Impressive-sounding certificates. Prices that make our pharmacy partners look expensive.
We delete them. Every one of them.
The volume tells you something. This isn't a niche corner of the internet anymore. Chainalysis reported in June that crypto payments to gray-market peptide vendors have grown for six straight quarters and are on track to pass a $100 million annual run rate in 2026, up from roughly $1 million a quarter in 2024. That's a lot of money flowing to people who will never meet you, never examine you and never answer for what's in the vial.
Who's Actually Selling It
It gets worse. The Wall Street Journal reported that a growing number of Chinese companies that have supplied fentanyl precursors to drug cartels are now selling unregulated peptides, and TRM Labs told the Journal that at least 50 of the more than 200 precursor suppliers it tracks were selling peptides. TRM's own research found that of the 150-plus Chinese chemical manufacturers it has identified accepting cryptocurrency, roughly three-quarters list both fentanyl precursors and peptides on their websites.
Read that again. The same supply chain behind one of the deadliest drug crises in American history is shipping the "BPC-157" in your fridge. The label says "for research use only." Everybody knows what it's actually for.
What's Actually in the Vial
This is where the club analogy stops being a metaphor.
Independent labs have started testing what people are actually buying, and the results should end the debate. Rina Dukor, co-founder of BioTools, a lab that has tested pharmaceuticals for drug companies and federal agencies, said almost 30% of the peptide samples analyzed through the consumer testing service Finnrick were mislabeled, underdosed, overdosed, or contaminated with toxins or bacteria. She said they find live or dead bacteria in a lot of the vials, and that this could lead to hospitalizations.
A 2026 analysis of research-grade peptides sold directly to consumers measured how much peptide was actually present compared with the amount stated on the label, and found wide variability in both purity and quantity. In plain English: some vials have far less of the drug than the label says. Some have more. Some have something else.
Think about what that means for an injection. When you swallow something, your gut, stomach acid and liver are a defensive line. When you inject it, you skip all of that. Bacterial endotoxin, a wrong compound, a 3x dose, it all goes straight in. A pill from a stranger at least has to get past your stomach. A syringe doesn't.
"But It Has a Certificate of Analysis"
So did every one of the emails in my inbox this week. A PDF is not a test. Even the testing companies warn about this. Finnrick tells buyers that COA PDFs can be fabricated or altered and should always be verified at the source. If the seller made the vial and also made the paperwork, you have exactly one source of truth, and it's the person who wants your money.
Where Regulation Actually Stands
You may have seen headlines this summer saying the FDA "approved" peptides. It didn't. At its July 23–24 meeting, the FDA's Pharmacy Compounding Advisory Committee narrowly recommended six peptides (BPC-157, KPV, TB-500, MOTS-c, Semax and Epitalon) for the 503A Bulks List, overriding the FDA's own career scientists, who had recommended against all seven under review. None of these peptides has been added to the list, none is an FDA-approved drug, and the FDA still has to decide whether to accept the nonbinding recommendations and then go through formal rulemaking.
The rules are still being written. That doesn't make the gray market more acceptable. It means the burden is on you, and on whoever is treating you, to know exactly what's going into your body. At Formula we take this burden very seriously.
How We Do It at Formula
Our standard is the reason those daily emails go nowhere.
Every peptide therapy at Formula starts with a consultation and a prescription from a licensed clinician. Every prescription is filled only through state-licensed 503A compounding pharmacies or FDA-registered 503B outsourcing facilities that have passed our vetting. That vetting includes an on-site inspection by our own team. We walk the facility. We don't take a sales deck's word for it.
We work with pharmacies that send each batch for independent third-party testing for sterility, potency, endotoxin and contaminants before it reaches a patient. Not a sample from last year. Not the manufacturer's own PDF. That batch.
We don't buy from research-chemical vendors. We don't buy from overseas labs. And if we can't verify a therapy's quality, we don't offer it, no matter how much patients ask for it. We aren't doing this for fun. We do this because we are medical professionals with medical licenses and believe as strongly about patient safety as we do about longevity.
Five Questions to Ask Anyone Selling You a Peptide
We know you have a choice to where you get your peptides, supplements hormones and aesthetic injections. Before you do
- Will a licensed clinician - trained in this medicine or procedure evaluate me and write a prescription?
- Is it coming from a U.S.-licensed 503A or FDA-registered 503B facility?
- Has your team inspected that pharmacy?
- Is this batch independently tested for sterility, potency and contaminants?
- Who is monitoring me, and who do I call if something goes wrong?
If the answer to any of these is a shrug, or the vial says "not for human consumption," you have your answer.
The Bottom Line
Peptides are real medicine with real promise. That's exactly why they deserve to be treated like medicine. You wouldn't take the pill from the stranger at the club. Don't take the syringe from a stranger on the internet. Your body is the one place where saving $100 is never the bargain.
